Melatonin as a Potential Treatment for SARS-CoV-2
More than 140 scientific studies suggest melatonin is a useful agent for treating SARS-CoV-2, according to research published in Cellular and Molecular Life Sciences.1 Despite this, and its known antiviral and anti-inflammatory effects, melatonin has received little attention as a countermeasure for COVID-19. After reviewing the published literature related to melatonin and SARS-CoV-2/COVID-19 in November… Read More »